Continuing Education Activity

Mosquitoes account for most insect bites worldwide and are found on every continent except Antarctica. Although more than 40 genera exist, Culex, Anopheles, and Aedes are responsible for most human disease transmission. Mosquito bites produce localized inflammatory reactions through salivary protein-mediated immune activation, resulting in pruritus, erythema, and edema. Clinical manifestations range from mild cutaneous irritation to hypersensitivity reactions and secondary bacterial infection from excoriation. Mosquitoes also serve as vectors for numerous pathogens, including malaria, dengue, yellow fever, Zika virus disease, chikungunya, and West Nile fever. This activity for healthcare professionals is designed to sharpen learners' skills in evaluating and managing mosquito bites. Participants will deepen their understanding of the condition's etiology, risk factors, pathophysiology, clinical presentation, potential complications, and evidence-based diagnostic, preventive, and therapeutic recommendations. Enhanced competence will empower clinicians to collaborate with interprofessional teams providing care for affected individuals.

Objectives:

• Differentiate mosquito bites from other common skin lesions based on history and physical findings.
• Implement personalized, evidence-based strategies for managing mosquito bites and mitigating possible complications.
• Improve patient awareness of effective mosquito bite preventive measures, expected local reactions, and indications for medical evaluation.
• Collaborate with the interprofessional team to educate, treat, and monitor patients at increased risk of mosquito bites or mosquito-borne diseases to improve health outcomes and public health preparedness.

Access free multiple choice questions on this topic.

Introduction

Mosquitoes are flying insects belonging to the family Culicidae and are found on every continent except Antarctica. Mosquitoes are a vital component of the ecosystem, serving as food for fish and birds and as pollinators for thousands of plant species. [Source: Rafferty, JP. What Purposes Do Mosquitoes Serve in Ecosystems? 2025] Mosquitoes are also responsible for most insect bites worldwide. Although mosquito bites are generally benign, mosquitoes serve as vectors for an increasing number of diseases, contributing a significant burden to public health.

Etiology

Although more than 3,700 mosquito species across 42 genera have been identified, only 3 genera are primarily responsible for clinically significant human bites: Anopheles, Culex, and Aedes.[1] [Source: Centers for Disease Control and Prevention. About Mosquitoes. 2024] Across these genera, only female mosquitoes bite, requiring a blood meal for egg development. Each genus demonstrates distinct feeding behaviors and activity patterns, relevant for preventive measures. Daytime-biting species belonging to the genus Aedes are often attracted to dark clothing and rely on olfactory cues, including carbon dioxide and lactic acid, during host location. Nighttime-biting species in the Anopheles and Culex genera may also use infrared radiation for host detection. [Reynolds, S. Mosquitoes use infrared detection to help find people. 2024] Evidence suggests that individual factors, including sweat composition, certain fragrances, and alcohol consumption, may increase mosquito attraction. A small study demonstrated increased mosquito attraction following alcohol consumption, highlighting behavioral influences on bite risk.[2]

Epidemiology

Mosquitoes are distributed worldwide, and the geographic range of many species continues to expand due to environmental changes, including rising temperatures and altered precipitation patterns.[3] These shifts have enabled species, such as Aedes aegypti and Aedes albopictus, to establish in new regions with warmer climates. Increased urbanization and land use changes further promote the spread of invasive species, increasing exposure risk to vector-borne diseases.

The true annual incidence of mosquito bites remains unknown due to underreporting. Data from the National Poison Data System documented only 75 reported cases during 1 study period, likely underestimating the overall burden.[4] In contrast, mosquito-borne diseases infect an estimated 700 million people and cause approximately 1 million deaths globally each year. Across species, only female mosquitoes bite to obtain blood for egg development. Feeding patterns vary by species, with some biting primarily during the day and others at night, making species-specific prevention strategies essential.

Pathophysiology

Mosquito biting behavior is influenced by environmental and host factors. At long range, mosquitoes rely primarily on olfactory cues, such as carbon dioxide and volatile organic compounds. At closer distances, visual signals, body heat, and short-range olfactory stimuli are integrated to identify suitable hosts. [Source: Zhang, et al. Decoding the Bite: Sensory cues, host heterogeneity, and pathogen manipulation in mosquito host-seeking behavior. 2025] Host-related risk factors vary across studies, although available evidence suggests increased risk among children and older adults. Larger body size, pregnancy, dark-colored clothing, and alcohol consumption are consistently associated with greater mosquito attraction.[5] Growing evidence also supports a role for skin microbiota, as microbial communities produce volatile organic compounds that influence host attractiveness. Data regarding sex and blood type remain inconsistent. Notably, infections such as dengue fever and malaria may alter host odor profiles, increasing vector attraction and facilitating pathogen transmission.

After host localization, the mosquito inserts its proboscis into the skin and injects saliva, triggering a range of immune responses. Repeated exposure may produce progression through 5 reaction stages: initial small local reaction; delayed-only reactions; combined immediate and delayed reactions; immediate-only reactions; and eventual desensitization. Experimental data demonstrate that desensitization may occur with repeated exposure, although the process may require longer periods in natural settings. In a study, desensitization in healthy volunteers was induced through exposure to 100 bites every 2 weeks for 10 months.[6]

Bite reactions are thought to result from 3 mechanisms: histamine-mediated pruritus, mast cell hypersensitivity mediated by immunoglobulin E (IgE), and IgE-independent, nonhistaminergic pathways, more common in delayed reactions. These processes also facilitate mosquito feeding through vasodilation and anticoagulant effects.

Several amplified immune responses have been identified in certain hosts following mosquito bites. Skeeter syndrome is a large local inflammatory reaction, more common in children with a history of atopic disease, though it also occurs in other populations. A triad consisting of hypersensitivity to mosquito bites (HMB), Epstein–Barr virus (EBV) infection, and natural killer (NK) cell proliferative disorder, known as HMB-EBV-NK syndrome, may present with bullae, ulceration, and necrosis secondary to an exaggerated immune response to mosquito bites. Additional populations, including individuals with prior arthropod hypersensitivity reactions, hematologic malignancy, and HIV infection, may also be at increased risk of amplified immune responses to mosquito bites.

History and Physical

A thorough history and physical examination is sufficient to diagnose mosquito bites. Patients typically report a sensation of a bite before the onset of cutaneous findings. Mosquito bites are usually painless compared with other insect bites. Wheals and papules are typically round with a central punctum. Extensive excoriation may obscure characteristic skin findings. Severe reactions may include lymphadenopathy, mild fever, and localized swelling, although these findings are uncommon. Anaphylaxis may occur, though rarely.

Evaluation

Although mosquito extracts for diagnostic testing are available, their clinical utility is limited due to their variable antigen content and potential for false-positive and false-negative results. Clinical trials may use mosquito bite testing to evaluate allergic responses to mosquito saliva, as well as immunotherapy and vaccine strategies targeting mosquito-borne pathogens.[7]

Most reactions are mild and self-limiting, and testing is generally unnecessary. In most cases, cutaneous findings have already resolved by the time evaluation for possible mosquito-borne illness occurs. For more significant reactions, such as Skeeter syndrome, coordination with allergy or immunology specialists may provide additional management guidance.

Treatment / Management

Prophylactic options are available for individuals at risk of mosquito bites. Second-generation antihistamines, including levocetirizine 5 mg, cetirizine 10 mg, and rupatadine 10 mg, have been evaluated in placebo-controlled trials and shown to reduce wheal size and pruritus in adults. In children, loratadine 0.3 mg/kg has been shown to decrease wheal size by 45% and pruritus by 78%.

For patients with severe local or systemic reactions, immunotherapy with whole-body mosquito extract has demonstrated symptom improvement in a study of 40 patients compared with baseline and placebo groups. However, larger trials are needed to confirm these findings.[8]

Topical therapies and oral antihistamines, including those listed above, may help reduce symptoms after a bite occurs. Limited clinical evidence supports the efficacy of topical agents, such as calamine lotion, glucocorticoids, or homeopathic remedies, highlighting the need for additional research. Despite limited mosquito-specific data, topical glucocorticoids have demonstrated benefit in other insect bites and are often used for mosquito bites, particularly when more pronounced reactions develop.

Differential Diagnosis

In general, the diagnosis of insect bites is straightforward. However, careful consideration is necessary to avoid misdiagnosis of other pruritic skin conditions.

Mosquito bites are frequently misdiagnosed as bacterial cellulitis, particularly in patients who are very young or have a history of atopic disease, who may exhibit exaggerated reactions to bites. A general rule of thumb is that mosquito bites develop over hours, whereas cellulitis progresses over days.[9] Cellulitis following mosquito bites is also a frequent consequence of excoriation of affected areas.

Prognosis

Local reactions from mosquito bites are usually self-limiting and do not persist beyond 10 days. However, mosquito-borne illnesses are associated with greater morbidity, and prognosis depends on the causative agent.[10]

Complications

Several uncommon complications require consideration. Anaphylaxis is very rare but requires prompt recognition and treatment.[11] Skeeter syndrome may occur in children, particularly those with atopic disease, as well as in immunocompromised patients. Characteristic features include fever and large areas of erythema developing within hours after the bite. Rapid symptom onset serves as a key distinguishing feature from cellulitis.[12]

Two distinct syndromes have been associated with amplified immune responses to mosquito bites. HMB-EBV-NK syndrome may present with localized bullae, ulceration, or necrosis at bite sites. Wells syndrome is an eosinophilic cellulitis characterized by erythematous, violaceous, blistering, and pruritic lesions, with some studies suggesting an association with mosquito bites.

Consultations

Consultation with an allergy or immunology specialist may help guide diagnostic decisions when treating patients with severe or amplified responses to mosquito bites. Further management may be optimized through specialist involvement.

Deterrence and Patient Education

Preventing mosquito bites is the most important intervention, as prevention reduces both local cutaneous reactions and mosquito-borne illness transmission. An initial step involves the elimination of breeding sites through the removal of standing water near the home, including that in plant pots, uncovered water containers, and used tires, which commonly serve as mosquito larval habitats.

At the individual level, patients are advised to wear long sleeves and pants and limit outdoor exposure during dusk and dawn—periods of increased mosquito activity. Research on repellent- and insecticide-free fabrics is ongoing, with a study identifying 3 commercially available products with the potential to reduce mosquito bites.[13] These findings may support the development of more effective bite-resistant clothing.

Diethyltoluamide (DEET) is the most commonly recommended and studied mosquito repellent to date. The mechanism of action of this chemical involves the creation of an olfactory and gustatory deterrent barrier that discourages biting. Although the safety profile is favorable with appropriate use, application to the face and overnight use should be avoided, particularly in children, due to increased risk of toxicity. Picaridin is a newer repellent with comparable efficacy to DEET but without the characteristic odor. Prior to the introduction of DEET, citronella was widely used as a primary insect repellent. However, head-to-head trials demonstrate approximately 1 hour of protection compared with up to 8 hours with DEET.[14] The selection of optimal repellent should involve shared decision-making to support safe and consistent application.

Mosquito nets are used to protect against mosquito bites at night. Treatment of nets with permethrin increases effectiveness. However, contact exposure should be minimized due to potential toxicity concerns.[15] Widespread use of insecticides, including insecticide-treated nets, has contributed to increasing pyrethroid resistance, highlighting the need for alternative prevention strategies.[Centers for Disease Control and Prevention. Insecticide-Treated-Nets. 2024]

Global eradication programs, including spraying of water sources and elimination of small standing water collections, have contributed to control but not elimination of mosquito-borne illnesses. Due to the persistence of mosquito-borne disease burden, newer approaches, such as radiofrequency exposure, Wolbachia-based methods, and sterile insect techniques, are under investigation for mosquito control and have demonstrated reductions in mosquito-borne disease risk.[16]

Enhancing Healthcare Team Outcomes

Mosquito bites can either become a minor nuisance or lead to serious medical conditions, including mosquito-borne illnesses and severe allergic reactions. In recent years, the incidence of dengue, West Nile virus disease, chikungunya, and Zika virus disease has increased in the US. Healthcare professionals must remain updated regarding the management of local reactions and strategies for preventing and mitigating emerging epidemics. The interprofessional team should collaborate in diagnosis, treatment, and patient education. Identification and management of mosquito bites and associated sequelae are best addressed through an interprofessional team approach, including primary care physicians, infectious disease specialists, midlevel practitioners, and nursing staff, including nurses with specialized training in infectious disease control, to ensure optimal patient care.

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Vander Does A, Labib A, Yosipovitch G. Update on mosquito bite reaction: Itch and hypersensitivity, pathophysiology, prevention, and treatment. Front Immunol. 2022;13:1024559. [PMC free article: PMC9532860] [PubMed: 36211437]

2.

Shirai O, Tsuda T, Kitagawa S, Naitoh K, Seki T, Kamimura K, Morohashi M. Alcohol ingestion stimulates mosquito attraction. J Am Mosq Control Assoc. 2002 Jun;18(2):91-6. [PubMed: 12083361]

3.

Fesce E, Martínez-de la Puente J, Ferraguti M. The ecology of biting: buzzing through the main ecological, environmental and biological drivers of mosquito-borne diseases. One Health. 2026 Jun;22:101326. [PMC free article: PMC12834940] [PubMed: 41607934]

4.

Beuhler MC, Feldman R, Gummin DD, Mowry JB, Rivers LJ, Brown K, Pham NPT, Johnson-O'Leary K, Spyker DA, Bronstein AC. 2024 Annual report of the National Poison Data System® (NPDS) from America's Poison Centers^®: 42nd annual report. Clin Toxicol (Phila). 2025 Dec;63(12):1029-1280. [PubMed: 41432769]

5.

Blanken SL, Prudhomme O'Meara W, Hol FJH, Bousema T, Markwalter CF. À la carte: how mosquitoes choose their blood meals. Trends Parasitol. 2024 Jul;40(7):591-603. [PMC free article: PMC11223952] [PubMed: 38853076]

6.

Peng Z, Simons FE. A prospective study of naturally acquired sensitization and subsequent desensitization to mosquito bites and concurrent antibody responses. J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):284-6. [PubMed: 9500765]

7.

Crisp HC, Johnson KS. Mosquito allergy. Ann Allergy Asthma Immunol. 2013 Feb;110(2):65-9. [PubMed: 23352522]

8.

Srivastava D, Singh BP, Sudha VT, Arora N, Gaur SN. Immunotherapy with mosquito (Culex quinquefasciatus) extract: a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2007 Sep;99(3):273-80. [PubMed: 17910332]

9.

Keller EC, Tomecki KJ, Alraies MC. Distinguishing cellulitis from its mimics. Cleve Clin J Med. 2012 Aug;79(8):547-52. [PubMed: 22854433]

10.

Karaman S. A rare allergic disease due to mosquito bite: Skeeter syndrome. Postepy Dermatol Alergol. 2025;42(5):475-479. [PMC free article: PMC12621206] [PubMed: 41256061]

11.

Singh S, Mann BK. Insect bite reactions. Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):151-64. [PubMed: 23442453]

12.

Simons FE, Peng Z. Skeeter syndrome. J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):705-7. [PubMed: 10482852]

13.

Hill E, Della Rocca MJ, Raban R, Herard N, Esho A, Sun MS, Edwards RTM, Boechler N, Akbari OS. Toward comfortable mosquito-proof clothing: repellent- and insecticide-free fabrics that block bites across three disease-transmitting mosquito genera. J Med Entomol. 2026 Jan 20;63(1) [PMC free article: PMC12823275] [PubMed: 41144297]

14.

Katz TM, Miller JH, Hebert AA. Insect repellents: historical perspectives and new developments. J Am Acad Dermatol. 2008 May;58(5):865-71. [PubMed: 18272250]

15.

Hołyńska-Iwan I, Szewczyk-Golec K. Pyrethroids: How They Affect Human and Animal Health? Medicina (Kaunas). 2020 Oct 30;56(11) [PMC free article: PMC7692614] [PubMed: 33143129]

16.

Defilippo F, Moreno A, Ciccozzi M, Losardo M, Bia P, Manna A, de Gara L, Giovanetti M. Disrupting vector competence: exploring radiofrequency exposure as a novel approach to mosquito-borne disease prevention in a changing climate. Pathog Glob Health. 2025 Dec;119(8):343-350. [PMC free article: PMC12897529] [PubMed: 41073070]

Disclosure: Aaron Farmer declares no relevant financial relationships with ineligible companies.

Disclosure: Ellis Tobin declares no relevant financial relationships with ineligible companies.

Disclosure: Shawn Horrall declares no relevant financial relationships with ineligible companies.